Literature DB >> 17429478

Compact multimodal adaptive-optics spectral-domain optical coherence tomography instrument for retinal imaging.

Chad E Bigelow1, Nicusor V Iftimia, R Daniel Ferguson, Teoman E Ustun, Benjamin Bloom, Daniel X Hammer.   

Abstract

We have developed a compact, multimodal instrument for simultaneous acquisition of en face quasi-confocal fundus images and adaptive-optics (AO) spectral-domain optical coherence tomography (SDOCT) cross-sectional images. The optical system including all AO and SDOCT components occupies a 60x60 cm breadboard that can be readily transported for clinical applications. The AO component combines a Hartmann-Shack wavefront sensor and a microelectromechanical systems-based deformable mirror to sense and correct ocular aberrations at 15 Hz with a maximum stroke of 4 microm. A broadband superluminescent diode source provides 4 mum depth resolution for SDOCT imaging. In human volunteer testing, we observed up to an 8 dB increase in OCT signal and a corresponding lateral resolution of <10 microm as a result of AO correction.

Entities:  

Mesh:

Year:  2007        PMID: 17429478     DOI: 10.1364/josaa.24.001327

Source DB:  PubMed          Journal:  J Opt Soc Am A Opt Image Sci Vis        ISSN: 1084-7529            Impact factor:   2.129


  27 in total

1.  Long eye relief fundus camera and fixation target with partial correction of ocular longitudinal chromatic aberration.

Authors:  Samuel Steven; Yusufu N Sulai; Soon K Cheong; Julie Bentley; Alfredo Dubra
Journal:  Biomed Opt Express       Date:  2018-11-07       Impact factor: 3.732

2.  Foveal fine structure in retinopathy of prematurity: an adaptive optics Fourier domain optical coherence tomography study.

Authors:  Daniel X Hammer; Nicusor V Iftimia; R Daniel Ferguson; Chad E Bigelow; Teoman E Ustun; Amber M Barnaby; Anne B Fulton
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-01-25       Impact factor: 4.799

3.  Ultrahigh-resolution optical coherence tomography with monochromatic and chromatic aberration correction.

Authors:  Robert J Zawadzki; Barry Cense; Yan Zhang; Stacey S Choi; Donald T Miller; John S Werner
Journal:  Opt Express       Date:  2008-05-26       Impact factor: 3.894

4.  Imaging of retinal vasculature using adaptive optics SLO/OCT.

Authors:  Franz Felberer; Matthias Rechenmacher; Richard Haindl; Bernhard Baumann; Christoph K Hitzenberger; Michael Pircher
Journal:  Biomed Opt Express       Date:  2015-03-23       Impact factor: 3.732

5.  Adaptive optics scanning laser ophthalmoscope with integrated wide-field retinal imaging and tracking.

Authors:  R Daniel Ferguson; Zhangyi Zhong; Daniel X Hammer; Mircea Mujat; Ankit H Patel; Cong Deng; Weiyao Zou; Stephen A Burns
Journal:  J Opt Soc Am A Opt Image Sci Vis       Date:  2010-11-01       Impact factor: 2.129

Review 6.  Review of adaptive optics OCT (AO-OCT): principles and applications for retinal imaging [Invited].

Authors:  Michael Pircher; Robert J Zawadzki
Journal:  Biomed Opt Express       Date:  2017-04-19       Impact factor: 3.732

7.  Adaptive optics SLO/OCT for 3D imaging of human photoreceptors in vivo.

Authors:  Franz Felberer; Julia-Sophie Kroisamer; Bernhard Baumann; Stefan Zotter; Ursula Schmidt-Erfurth; Christoph K Hitzenberger; Michael Pircher
Journal:  Biomed Opt Express       Date:  2014-01-10       Impact factor: 3.732

8.  Adaptive optics retinal imaging: emerging clinical applications.

Authors:  Pooja Godara; Adam M Dubis; Austin Roorda; Jacque L Duncan; Joseph Carroll
Journal:  Optom Vis Sci       Date:  2010-12       Impact factor: 1.973

9.  High resolution multimodal clinical ophthalmic imaging system.

Authors:  Mircea Mujat; R Daniel Ferguson; Ankit H Patel; Nicusor Iftimia; Niyom Lue; Daniel X Hammer
Journal:  Opt Express       Date:  2010-05-24       Impact factor: 3.894

10.  Real-time processing for Fourier domain optical coherence tomography using a field programmable gate array.

Authors:  Teoman E Ustun; Nicusor V Iftimia; R Daniel Ferguson; Daniel X Hammer
Journal:  Rev Sci Instrum       Date:  2008-11       Impact factor: 1.523

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.